Clonazepam oral droplets for the treatment of acute epileptic seizures.
Oral droplet formulations of clonazepam (CZ) were developed to examine their potentials as an alternative to i.v. administration for the treatment of acute epileptic seizures. Propylene glycol containing 2.5% (wt/wt) CZ with or without 5.0% (wt/wt) oleic acid (OA) was prepared as a solution by heating at 90 degrees C and subsequently lowering the temperature to 30 degrees C. The droplet (20 microL) was administered to the oral cavity between the lower gum and bottom lip before CZ precipitation started. With a droplet of propylene glycol loaded with 2.5% (wt/wt) CZ and 5.0% (wt/wt) OA, the plasma concentration reached 20 ng/mL (minimal effective concentration) within 10 min and was maintained between 20 and 60 ng/mL, less than a toxic level, for a period of 60 min. For a droplet of propylene glycol loaded only with CZ at 2.5% (wt/wt), it took more than 15 min for the plasma concentration to reach 20 ng/mL. It is suggested that a droplet of CZ/OA/propylene glycol (2.5:5.0:92.5, wt/wt) might be useful as an alternative to i.v. injection of CZ for the treatment of acute epileptic seizures.
Sakata
Osamu
O
Department of Drug Delivery Research, Hoshi University, Tokyo, Japan.
Onishi
Hiraku
H
Machida
Yoshiharu
Y
D000208:Acute Disease; D000284:Administration, Oral; D000818:Animals; D000927:Anticonvulsants / Q000008:administration & dosage*; D002998:Clonazepam / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D004827:Epilepsy / Q000188:drug therapy*; D007408:Intestinal Absorption; D008297:Male; D051381:Rats; D017208:Rats, Wistar
D000927:Anticonvulsants; D002998:Clonazepam